Dana-Farber wins legal dispute over PD-1/PD-L1 patents; BMS set to lose exclusive license

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

So, you’ve finished your copy of the Mueller Report and you long for another great read from the same publisher—the U.S. government.

To access this subscriber-only content please log in or renew you subscription.

Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.

Login Subscribe


Mainstream tobacco control advocates are celebrating the recent announcement that the Food and Drug Administration is poised to restrict the manufacture and sale of mentholated cigarettes and cigars. Making national and international headlines, the messaging related to the long-awaited decision is that the FDA is “taking urgent action to reduce tobacco addiction and curb deaths.” Clearly, urgency is in the eye of the beholder.
Editor & Publisher